Latest Healthcare Research Reports

Author: The Business Research Company

Future Growth Forecast For The Renal Biomarkers Global Market 2024-2033
The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.

The renal biomarkers market has witnessed robust growth, emerging as a critical player in medical diagnostics. From $1.17 billion in 2023, the market is projected to reach $1.27 billion in 2024, showcasing a compelling Compound Annual Growth Rate (CAGR) of 8.1%. This growth is attributed to factors such as the increasing prevalence of kidney diseases, advances in medical diagnostics, and the rising awareness of early disease detection.

Global Growth Trajectory: Expectations are high for the renal biomarkers market, with projections indicating a substantial increase to $1.74 billion by 2028, boasting a CAGR of 8.1%. The driving forces behind this growth include personalized medicine, targeted therapies, integration of biomarker testing into routine clinical practice, the emergence of markets in Asia and Latin America, non-invasive biomarker testing methods, and continuous monitoring with wearable devices.

Major Trends Shaping the Future:
1. Multiplex Biomarker Panels: Comprehensive disease profiling through the use of multiple biomarkers.
2. AI and Machine Learning: Leveraging artificial intelligence for biomarker discovery.
3. Biomarker-Based Companion Diagnostics: Integrating biomarkers into diagnostic tools for personalized treatments.
4. POC Biomarker Testing in Home Healthcare: Bringing biomarker testing to home healthcare settings.
5. Biomarkers for Early Detection and Prevention: A focus on biomarkers to detect diseases at an early stage.
Rising Demand for Renal Biomarkers: Impact of Geriatric and Pediatric Patients: The increase in geriatric and pediatric renal patients is anticipated to be a key driver for the market. With chronic kidney disease (CKD) prevalent among elderly individuals and renal disorders affecting children, renal biomarkers play a crucial role in assessing the severity of renal injury. The Centers for Disease Control and Prevention (CDC) reports that nearly 37 million adults in the US have chronic renal disease, with a higher prevalence in those aged 65 and older.

Key Players Paving the Way: Major companies contributing to the renal biomarkers market include Abbott Laboratories, Roche Holding AG, Siemens Healthineers, and others. Their impact on the industry is instrumental in driving innovation and expanding the applications of renal biomarkers.

View More On The Renal Biomarkers Market Report 2024 – https://www.thebusinessresearchcompany.com/report/renal-biomarkers-global-market-report

Innovative Technologies Transforming the Market: Technological advancements stand out as a significant trend in the renal biomarkers market. RenalytixAI, a UK-based company, exemplifies this trend with its development of KidneyIntelX, a diagnostic tool powered by artificial intelligence to identify those at risk of renal disease or kidney failure. The partnership with DaVita and Joslin Diabetes Center further emphasizes the commitment to advancing diagnostic capabilities.

RenalytixAI’s Partnerships for Biomarker Advancements: RenalytixAI’s partnership with DaVita in January 2021 resulted in the development of KidneyIntelX, a diagnostic tool leveraging AI to assess the risk of renal disease or kidney failure. The machine-learning algorithm produces a patient-specific risk assessment based on blood biomarkers and electronic medical information.

Integration with Joslin Diabetes Center for Enhanced Biomarkers: In April 2021, RenalytixAI collaborated with the Joslin Diabetes Center, integrating novel biomarkers for chronic kidney disease. This partnership enhances KidneyIntelX’s capabilities in evaluating adverse kidney outcomes in people with Type 2 diabetes and early kidney disease.

Market Segmentation: The renal biomarkers market is segmented based on:
1. Biomarker Type: Functional Biomarker, Up Regulated Protein, Other Biomarker Types
2. Diagnostic Technique: Enzyme-Linked Immunosorbent Assay, PETIA, Colorimetric Assay, CLIA, LC-MS
3. Application: Diagnosis And Disease Progression Monitoring, Research Homecare
4. End User: Hospitals, Diagnostic Laboratories, Other End Users
Regional Dynamics: In 2023, North America dominated the renal biomarkers market, while Asia-Pacific is anticipated to be the fastest-growing region during the forecast period. This regional shift emphasizes the global nature of the renal biomarkers market.

Conclusion: The renal biomarkers market’s trajectory highlights its pivotal role in modern healthcare. With a focus on technological innovations, strategic partnerships, and a commitment to personalized medicine, the industry is poised for continued growth and transformative advancements in renal diagnostics.

Request A Sample Of The Global Renal Biomarkers Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=7711&type=smp
January 19, 2024
Top 5 Insights From The Rehabilitation Robotics Market Report 2024

The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

According to The Business Research Company’s Rehabilitation Robotics Global Market Report 2024, the rehabilitation robotics market is expected to show promising growth in the forecast period.

The rehabilitation robotics market has witnessed an exponential growth surge, catapulting from $1.22 billion in 2023 to a projected $1.51 billion in 2024, marking a substantial compound annual growth rate (CAGR) of 24.2%. This remarkable growth can be attributed to the burgeoning demand for rehabilitation and physical therapy services, a need for precision and targeted therapy, the expanding aging population and prevalence of chronic conditions, development of advanced robotic rehabilitation devices, and the establishment of regulatory standards ensuring medical device safety.

Future Projections: Unprecedented Growth Ahead

The rehabilitation robotics market is poised for continued exponential growth, projecting a market size of $3.37 billion in 2028, driven by a robust CAGR of 22.2%. Anticipated factors in the forecast period include the customization of rehabilitation robotics for specific patient needs, integration of artificial intelligence (AI) and machine learning in rehabilitation, the emergence of sustainable and cost-effective rehabilitation robotics, an expansion in tele-rehabilitation and remote monitoring, and the adoption of rehabilitation robotics in sports medicine. Key trends in the forecast period encompass regulatory compliance in rehabilitation robotics safety, smart and adaptive robotic rehabilitation solutions, personalized rehabilitation programs and progress tracking, transparency in rehabilitation robotics data and outcomes, and the integration of virtual reality and gamification in therapy.

Growing Geriatric Population Fuels Rehabilitation Robotics Market Growth

Impact of Aging Population:

The rehabilitation robotics market is poised to benefit significantly from the growing geriatric population globally. As individuals age, they become more susceptible to age-related health conditions such as strokes, Parkinson’s disease, and osteoarthritis. The application of rehabilitation robotics becomes pivotal in aiding older adults to recover and regain mobility and independence post-health events. With the world’s population aged 60 and above expected to reach 2.1 billion by 2050, the demand for rehabilitation robotics is propelled by the needs of this aging demographic.

Key Players:

Major players contributing to the growth of the rehabilitation robotics market include Myomo Inc., Bionik Laboratories Corporation, Hocoma AG, Cyberdyne Inc., and ReWalk Robotics Ltd. These companies play vital roles in developing innovative solutions to meet the evolving needs of the market.

View More On The Rehabilitation Robotics Market Report 2024 – https://www.thebusinessresearchcompany.com/report/rehabilitation-robotics-global-market-report

Rapid Adoption Of Assistive Robotics Drives Advancements In The Rehabilitation Robotics Market

Accelerated Adoption of Assistive Robotics:

A prominent trend in the rehabilitation robotics market is the rapid adoption of assistive robotics for enhanced and accelerated treatment. The medical field is witnessing a surge in the adoption of assistive robots to facilitate faster and more effective treatment processes. For instance, Labrador Systems, Inc. introduced the Labrador Retriever, a personal robot designed to offer hands-on assistance with daily tasks, easing the burden on individuals impacted by chronic pain, injuries, or medical conditions.

Strategic Acquisitions for Market Expansion:

In August 2023, ReWalk Robotics acquired AlterG for $19 million, aiming to expand access to innovative rehabilitation technologies for use both in clinics and at home. This strategic move demonstrates the industry’s commitment to widening the availability of advanced rehabilitation solutions.

Navigating Rehabilitation Robotics Market Segmentation

Comprehensive Segmentation:

The rehabilitation robotics market is segmented based on type, patient type, part, application, and end-user. Types include Exoskeleton Robots, Therapeutic Robots, Assistive Robots, and Prosthetic Robots. Patient types encompass Adult and Pediatrics, while parts include Lower Extremity and Upper Extremity. Applications cover Gait Therapy and Limb Mobility, and end-users include Rehabilitation Centers and Hospitals.

Regional Dynamics:

North America took the lead as the largest region in the rehabilitation robotics market in 2023, with expectations to maintain its position as the fastest-growing region during the forecast period. This regional dominance is indicative of the region’s robust focus on healthcare innovation.

Conclusion: Pioneering a Future of Enhanced Rehabilitation

In conclusion, the rehabilitation robotics market is not only experiencing unprecedented growth but is also witnessing transformative advancements. The intersection of technology, innovation, and strategic partnerships is propelling the industry forward. As we chart the course ahead, the rehabilitation robotics landscape holds the promise of not just meeting the needs of the aging population but also ushering in a new era of personalized, adaptive, and technologically integrated rehabilitation solutions.

Request A Sample Of The Global Rehabilitation Robotics Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=6422&type=smp

January 19, 2024
Overview Of The Referral Management Market 2024-2033: Growth And Major Players Analysis
The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

The referral management market has witnessed exponential growth in recent years, surging from $4.03 billion in 2023 to a projected $4.78 billion in 2024, boasting a remarkable compound annual growth rate (CAGR) of 18.7%. This trajectory can be attributed to various factors such as the expansion of healthcare services and patient referrals, the demand for coordinated care and specialist access, the growth of electronic health records and data sharing, the development of referral management software, and the establishment of regulatory standards for patient data privacy.

Factors Driving Growth in the Historic Period
- Growth in healthcare services and patient referrals
- Demand for coordinated care and specialist access
- Expansion of electronic health records and data sharing
- Development of referral management software
- Regulatory standards for patient data privacy
Factors Propelling Growth in the Forecast Period
- Customized referral management solutions for specific healthcare organizations
- Integration of AI and predictive analytics in referrals
- Sustainable and eco-friendly referral management practices
- Expansion in digital health and remote monitoring
- Adoption of referral management in population health
Major Trends in the Forecast Period
- Regulatory compliance in patient data security and referral processes
- Smart and automated referral management solutions
- Personalized referral pathways for specific patient needs
- Transparency in referral networks and patient outcomes
- Integration of AI for real-time referral optimization
Government Initiatives Driving IT Adoption

The integration of IT solutions in healthcare systems, spurred by government initiatives, is expected to be a significant driver of growth in the referral management market. Notably, the Indian government launched the Ayushman Bharat Digital Health Mission in 2021, aiming to digitalize health infrastructure in India with an allocated budget of $11.5 billion. Such initiatives enhance the delivery of accurate, actionable, and accessible information related to patients’ health, contributing to the growth of referral management.

Industry Leaders Shaping the Landscape

Several major companies play a crucial role in shaping the referral management market:
- Allscripts Healthcare Solutions Inc.
- CarePort Health Inc.
- The Advisory Board Company
- eHealth Technologies Inc.
- And many more…
Introduction of Innovative Solutions
Innovation is at the forefront of the referral management market, with major companies introducing advanced technological solutions to streamline and enhance healthcare processes. For instance, WellSky, a US-based healthcare technology company, introduced the Enterprise Referral Manager. This software centralizes referrals, integrating referral data into the EHR to improve the referral process, particularly for home health, hospice, and other home-based care agencies.

Strategic Acquisitions for Market Expansion

In January 2021, AristaMD, a US-based e-consult and referral management services provider, acquired Preferral, a company specializing in software and referral management systems. This strategic acquisition aids AristaMD in strengthening its referral management capabilities, developing new technologies, improving care, and providing services at lower costs.

Comprehensive Market Segmentation

The referral management market is intricately segmented to provide a nuanced understanding of its dynamics:
1. By Type:
  - Self-Referral
  - Professional-Referral
  - Third Party-Referral
2. By Component:
  - Software
  - Services
3. By Delivery Mode:
  - Web-Based Delivery Mode
  - Cloud-Based Delivery Mode
  - On-Premise Delivery Mode
4. By End User:
  - Provider
  - Payer
  - Other End Users
Regional Dynamics

North America emerged as the largest region in the referral management market in 2023, with Asia-Pacific expected to be the fastest-growing region in the forecast period. This geographical shift underscores the global nature of the market, reflecting widespread adoption and application of referral management solutions.

In conclusion, the referral management market is poised for rapid growth, driven by government initiatives, technological innovations, strategic acquisitions, and the introduction of advanced solutions. With major players leading the way, the market is set to transform healthcare processes and usher in a new era of efficient and coordinated patient care.

View More On The Referral Management Market Report 2024 – https://www.thebusinessresearchcompany.com/report/referral-management-global-market-report

Request A Sample Of The Global Referral Management Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=6851&type=smp
January 19, 2024
What Is The Forecast Growth Rate For The Real World Evidence Solutions Market?
The Business Research Company’s market reports offer an in-depth analysis on the market’s growth potential, major drivers, key trends and more.

The real-world evidence solutions market has witnessed substantial growth in recent years, with a promising trajectory for the future.

Market Expansion
- Growing from $1.75 billion in 2023 to $2.02 billion in 2024, showcasing a robust CAGR of 15.3%.
- Projections for the future anticipate reaching $3.58 billion in 2028, sustaining a strong CAGR of 15.4%.
Historical Drivers
- Growth in pharmaceutical and healthcare sectors.
- Demand for post-market surveillance and drug safety.
- Expansion of electronic health records and data.
- Adoption in clinical research and outcomes assessment.
- Regulatory standards for real-world evidence (RWE).
Catalysts for Future Growth

Customized RWE Solutions
- The forecast period anticipates tailored RWE solutions for specific therapeutic areas.
- Meeting the unique needs of different medical domains is expected to drive market growth.
Expansion of Real-World Data Networks
- The growth trajectory includes an expansion of real-world data networks.
- A broader network enhances the depth and breadth of data available for evidence generation.
Innovation in Evidence Generation
- The forecast sees an emphasis on innovation in real-world evidence generation.
- Novel approaches aim to enhance the quality and relevance of evidence in healthcare decision-making.
Collaboration in Drug Development
- The adoption of RWE in drug development and access is a significant driver.
- Collaborative efforts between healthcare and technology sectors are expected to shape the future landscape.
Emerging Trends in the Forecast Period

AI-Driven Predictive Analytics
- AI-driven predictive analytics in RWE is a notable trend.
- Advanced technologies contribute to more accurate predictions and insights.
Regulatory Compliance
- Ensuring regulatory compliance in RWE data privacy and security is gaining prominence.
- Stricter adherence to regulations enhances trust and reliability in real-world evidence.
Personalized RWE Solutions
- Personalized RWE solutions for healthcare providers are becoming prevalent.
- Tailoring evidence to specific healthcare contexts improves its applicability.
Transparency in Data Sharing
- Transparency in data sharing and RWE findings is a growing trend.
- Open communication fosters trust and collaboration in the healthcare ecosystem.
Integration in Drug Pricing
- The integration of RWE in drug pricing and reimbursement is gaining traction.
- Evidence-based pricing strategies contribute to a more sustainable healthcare system.
Government Support as a Driving Force

Fostering a Favorable Environment
- Government support plays a pivotal role in driving market growth.
- Efforts to raise public awareness create a conducive environment for the adoption of RWE solutions.
Global Initiatives
- International initiatives, such as the UK government’s investment in medical device approval bodies, showcase global support.
- National agencies, like Romania’s National Agency for Health Infrastructure Development, contribute to a cohesive healthcare ecosystem.
Noteworthy Market Players

Maxis Clinical Sciences’ RWE Solutions
- Maxis Clinical Sciences introduces a new RWE Solutions service.
- Optimizing evidence-based medicine, the service combines various real-world data sources.
Cerner Corporation’s Strategic Acquisition
- Cerner Corporation enters the RWE solutions market with the acquisition of Kantar Health.
- The $375 million deal brings together Cerner’s real-world data and Kantar Health’s life sciences expertise.
Market Segmentation
1. Component
  - Services
  - Data Sets
  - Clinical Setting Data
  - Claims Data
  - Pharmacy Data
  - Patient Powered Data
2. Therapeutic Area
  - Oncology
  - Cardiovascular
  - Neurology
  - Immunology
  - Other Therapeutic Areas
3. Application
  - Drug Development And Approvals
  - Medical Device Development And Approvals
  - Reimbursement/Coverage And Regulatory Decision Making
  - Post Market Safety And Adverse Events Monitoring
4. End-Users
  - Pharmaceutical And Medical Devices Companies
  - Healthcare Providers
  - Healthcare Payers
  - Other End-Users
Regional Dynamics

North America’s Leading Role
- North America dominated the real-world evidence solutions market in 2023.
- Robust healthcare infrastructure and research capabilities contribute to the region’s prominence.
Asia-Pacific’s Growth Potential
- Asia-Pacific emerges as the fastest-growing region in the forecast period.
- Increasing disease burden and emerging markets contribute to the region’s anticipated growth.
In conclusion, the real-world evidence solutions market is poised for continued growth, fueled by government support, innovative solutions, and strategic collaborations. Emerging trends and evolving technologies promise to reshape the landscape, providing a solid foundation for evidence-based decision-making in the healthcare industry.

Read More On The Real World Evidence Solutions Market Report 2024 – https://www.thebusinessresearchcompany.com/report/real-world-evidence-solutions-global-market-report

Request for A Sample Of The Global Real World Evidence Solutions Market Report:
https://www.thebusinessresearchcompany.com/sample_request?id=6930&type=smp
January 19, 2024
Global Pyrogen Testing Market Analysis 2024: Size, Share, And Key Trends
The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

As per The Business Research Company’s Pyrogen Testing Global Market Report 2024, the pyrogen testing market is expected to show significant growth in the forecast period.
1. Introduction
The pyrogen testing market has witnessed rapid growth, emerging as a critical player in ensuring the safety of pharmaceutical and biotechnological products. In 2023, the market size reached $1.46 billion, projected to soar to $1.67 billion in 2024, boasting a Compound Annual Growth Rate (CAGR) of 14.2%. Looking ahead, the forecast is equally promising, with an anticipated growth to $2.72 billion in 2028, marking a CAGR of 13.0%. This robust growth can be attributed to various factors, including the rise in infectious diseases, advancements in testing methods, and increased adoption in medical device manufacturing.
1. Infectious Diseases Driving Market Demand
2. Pyrogen Testing Crucial for Safety
- Pyrogen testing plays a pivotal role in detecting fever-causing contaminants in drugs and medical devices.
- Essential step to ensure the safety of pharmaceutical products.
1. Rise in Infectious Diseases
- According to the Centers for Disease Control and Prevention, there has been an increase in central line-associated bloodstream infection (CLABSI) and catheter-associated urinary tract infection (CAUTI) between 2020 and 2021.
- Global increase in infectious diseases propels the growth of the pyrogen testing market.
1. Major Companies in the Pyrogen Testing Market
- Key Players:
  - Thermo Fisher Scientific Inc.
  - Merck KGaA
  - Charles River Laboratories Inc.
  - Lonza Group Ltd.
  - Associates of Cape Cod Inc.
  - GenScript Biotech Corporation
  - Eurofins Scientific SE
  - SGS SA
  - Bio-Rad Laboratories Inc.
  - STERIS Corporation
View More On The Pyrogen Testing Market Report 2024 – https://www.thebusinessresearchcompany.com/report/pyrogen-testing-global-market-report
1. Animal-Free Pyrogen Testing Innovations
2. Evolution of Animal-Free Methods
- Companies focus on animal-free pyrogen testing methods, such as the monocyte activation assay (MAT).
- Overcoming constraints of traditional rabbit pyrogen testing and Limulus Amebocyte Lysate (LAL) test.
1. Merck’s PyroDetect and PyroMAT Systems
- Merck introduces two MAT systems, PyroDetect and PyroMAT, for the detection of both endotoxin and non-endotoxin pyrogens.
- These systems aim to provide a human treatment of animals and offer better predictability of pyrogenic activity.
1. Market Segmentation and Regional Insights
- Segmentation:
  1. By Test Type: LAL Test, In Vitro Test, Rabbit Test
  2. By Product And Service: Assays, Kits, And Reagents, Instruments, Services
  3. By Application: Pharmaceutical And Biologics, Medical Devices, Other Applications
- Regional Insights:
- - North America dominated the pyrogen testing market in 2023.
  - Asia-Pacific is projected to be the fastest-growing region during the forecast period.
1. Conclusion
As the pyrogen testing market continues to flourish, driven by the imperative need for product safety in pharmaceutical and biotechnological industries, it stands at the forefront of ensuring health and well-being. The ongoing innovations in animal-free testing methods and the relentless focus on addressing infectious diseases emphasize the industry’s commitment to advancing healthcare safety standards. Stakeholders in the pyrogen testing market are poised to play a pivotal role in the dynamic landscape of health protection, fostering transparency, traceability, and personalized solutions in the testing processes.

Request A Sample Of The Global Pyrogen Testing Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=4020&type=smp
January 19, 2024
Global Prosthetics & Orthotics Market Overview 2024: Size, Drivers, And Trends
The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.

The prosthetics & orthotics market has exhibited robust growth, witnessing an increase from $8.1 billion in 2023 to a projected $8.62 billion in 2024 at a Compound Annual Growth Rate (CAGR) of 6.5%. The historical growth is attributed to factors such as the rising prevalence of disabilities and amputations, advancements in materials and manufacturing techniques, increasing awareness and acceptance of prosthetics, healthcare infrastructure development, and the growth in sports and rehabilitation.
- Drivers of Historical Growth
  - Rising Prevalence of Disabilities and Amputations
  - Advancements in Materials and Manufacturing Techniques
  - Increasing Awareness and Acceptance of Prosthetics
  - Healthcare Infrastructure Development
  - Growth in Sports and Rehabilitation
Anticipating Strong Growth Ahead
The prosthetics & orthotics market is poised for continued strong growth, projected to reach $10.74 billion in 2028, reflecting a CAGR of 5.6%. The forecasted surge is fueled by various factors, including the adoption of customized and patient-specific prosthetic solutions, integration of AI and robotics, sustainable and eco-friendly prosthetic materials, expansion in pediatric prosthetics and orthotics, and the growing adoption of telehealth for orthotic services.
- Factors Driving Future Growth
  - Customized and Patient-Specific Prosthetic Solutions
  - Integration of AI and Robotics in Prosthetics
  - Sustainable and Eco-Friendly Prosthetic Materials
  - Expansion in Pediatric Prosthetics and Orthotics
  - Adoption of Telehealth for Orthotic Services
Surge in Demand: Sports Injuries and Road Accidents
The prosthetics and orthotics market is expected to experience a surge in demand due to the increase in sports injuries and road accidents. Road accidents, often caused by distracted driving and high speeding, result in disabilities that necessitate prosthetics and orthotics for recovery. Similarly, sports injuries, driven by year-round participation in a single sport, contribute to the demand for these medical aids.
- Impact of Road Accidents on Market Demand
- Prevalence of Sports Injuries and its Contribution
- Statistics on Road Crash Deaths in India
- Growing Cases of Sports Injuries in the US
Key Players Shaping the Landscape
Major companies operating in the prosthetics & orthotics market play a pivotal role in driving innovation and meeting the evolving needs of patients. Key players include Fillauer LLC, Bauerfeind AG, Otto Bock Healthcare GmbH, Zimmer Biomet Holdings Inc., and others.
- Fillauer LLC
- Bauerfeind AG
- Otto Bock Healthcare GmbH
- Zimmer Biomet Holdings Inc.
- Major Companies in the Market
View More On The Prosthetics & Orthotics Market Report 2024 – https://www.thebusinessresearchcompany.com/report/prosthetics-and-orthotics-global-market-report

Technological Leap: Innovations Fueling Market Growth
Technological innovation has become a defining trend in the prosthetics and orthotics market, with companies embracing advancements such as automation, artificial intelligence (AI), microprocessor technology, neuromuscular signal technology, and sensory control. Notable examples include Ossur’s launch of the POWER KNEE, the first actively powered microprocessor prosthetic knee.
- Technological Advancement in the Market
- Incorporation of AI, Robotics, and Microprocessor Technology
- Ossur’s POWER KNEE: A Revolutionary Product
Strategic Acquisition: Össur Strengthens its Position
In a strategic move, Össur, an Iceland-based orthotics and prosthetics (O&P) company, acquired Naked Prosthetics in August 2022. This acquisition aims to address the needs of individuals with finger and partial hand loss, enhancing Össur’s global upper-limb product portfolio.
- Strategic Acquisition by Össur
- Naked Prosthetics’ Role in Upper-Limb Solutions
- Strengthening Össur’s Global Portfolio
Market Dynamics: Segmentation Insights
Understanding the diverse landscape of prosthetics & orthotics is crucial. The market is segmented based on types, categories, technologies, and applications.
1. By Type:
- Prosthetics
- Orthotics
1. By Category:
- Upper Limb
- Lower Limb
- Spinal
1. By Technology:
- Conventional
- Electric-Powered
- Hybrid Orthopedic Prosthetics
1. By Application:
- Hospitals
- Clinics
- Rehabilitation Centers
- Other Applications
Regional Dynamics: North America Leads the Way
In 2023, North America emerged as the largest region in the prosthetics & orthotics market. However, the Asia-Pacific region is expected to witness the fastest-growing market share during the forecast period, indicating a shift in global healthcare dynamics.
- North America’s Dominance
- Asia-Pacific’s Accelerated Growth
In Conclusion
As the prosthetics & orthotics market continues to evolve, fueled by technological advancements, strategic acquisitions, and a growing awareness of the diverse needs of individuals with disabilities, it is poised to play a crucial role in enhancing the quality of life for many. The commitment of key players to innovation, coupled with an increasing focus on sustainability and patient-centric solutions, positions the market for a dynamic and transformative future.

Request A Sample Of The Global Prosthetics & Orthotics Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=6915&type=smp
January 19, 2024
Global Pre Filled Syringes Market Key Insights 2024-2033
The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

According to The Business Research Company’s Pre Filled Syringes Global Market Report 2024, the pre filled syringes market is expected to show promising growth in the forecast period.

The pre-filled syringes market has experienced a rapid surge, becoming a vital component in drug delivery systems. Growing from $7.42 billion in 2023 to $8.51 billion in 2024, at a remarkable Compound Annual Growth Rate (CAGR) of 14.8%, this market is characterized by factors such as the expansion of the pharmaceutical and biotechnology industry, an increased demand for user-friendly drug delivery, and regulatory standards for drug safety.

Global Growth Trajectory: Anticipating sustained growth, the pre-filled syringes market is projected to reach $14.46 billion by 2028, with a CAGR of 14.2%. This surge is attributed to various factors, including customized pre-filled syringe solutions, biodegradable and sustainable materials, innovations in connected and smart syringes, increased utilization in telemedicine, and the adoption of long-acting injectable medications.

View More On The Pre Filled Syringes Market Report 2024 – https://www.thebusinessresearchcompany.com/report/pre-filled-syringes-global-market-report

Major Trends Shaping the Future:
1. Regulatory Compliance: Emphasis on ensuring pre-filled syringe safety and adherence to regulations.
2. Smart and Connected Syringes: Integration of technology for precise dosing and improved patient outcomes.
3. Biodegradable and Eco-Friendly Materials: A shift towards sustainable materials for syringe production.
4. Personalized Solutions: Tailoring pre-filled syringe solutions for specific patient populations.
5. Transparency and Traceability: Enhanced tracking and traceability in drug delivery processes.
Surge In Home-Based Healthcare Fuels Market Growth: The rise in home-based healthcare is a significant driving force for the pre-filled syringes market. As the healthcare landscape evolves, more patients are opting for home-based care. The market plays a pivotal role in meeting the demands of this growing trend by ensuring precise dosing, reducing contamination risks, and improving patient compliance. With approximately 12 million Americans receiving home healthcare each year, as reported by the National Association for Home Care and Hospice, the market is poised for substantial growth.

Key Players Paving the Way: Major companies contributing to the pre-filled syringes market include Becton, Dickinson and Company, Gerresheimer AG, West Pharmaceutical Services Inc., and others. Their commitment to innovation and quality has positioned them as key players in driving market growth.

Next-Generation Pre-Filled Syringes Are Gaining Popularity: Companies are investing significantly in next-generation pre-filled syringes, incorporating advanced features that allow healthcare professionals to track and access data. For instance, Becton, Dickinson and Company unveiled a next-generation glass prefillable syringe in September 2022, meeting stricter requirements for processability, cosmetics, integrity, and contamination. These next-gen syringes are designed to improve drug delivery, enhance patient safety, and adapt to the changing requirements of vaccine production.

Market Segmentation: The pre-filled syringes market is segmented based on:
1. Type: Conventional Prefilled Syringes, Safety Prefilled Syringes
2. Material: Glass Prefilled Syringes, Plastic Prefilled Syringes
3. Design: Single-Chamber Prefilled Syringes, Dual-Chamber Prefilled Syringes, Customized Prefilled Syringes
4. Application: Diabetes, Rheumatoid Arthritis, Anaphylaxis, Cancer, Thrombosis, Ophthalmology, Other Applications
Regional Dynamics: In 2023, Europe dominated the pre-filled syringes market, showcasing its prominence in the pharmaceutical industry. As the industry expands, regions like Asia-Pacific are expected to witness substantial growth during the forecast period.

Conclusion: The pre-filled syringes market’s trajectory reflects its pivotal role in the evolving landscape of drug delivery systems. With a focus on innovation, sustainability, and personalized solutions, the industry is poised for continued growth and transformative advancements, ensuring precise and patient-centric drug administration.

Request A Sample Of The Global Pre Filled Syringes Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=4115&type=smp
January 19, 2024
Positive Airway Pressure Devices Market Forecast 2024: Forecast Market Size, Drivers And Key Segments

The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

The positive airway pressure devices market has undergone a rapid expansion, surging from $3.94 billion in 2023 to a projected $4.37 billion in 2024, showcasing a substantial compound annual growth rate (CAGR) of 10.9%. This growth can be attributed to the burgeoning demand for sleep apnea and respiratory therapy, the increasing aging population coupled with the prevalence of chronic diseases, the expanding domain of home healthcare solutions, utilization in neonatal and pediatric care, and the establishment of stringent regulatory standards ensuring the safety of medical devices.

Anticipated Growth: A Bright Horizon
The positive airway pressure devices market is poised for continued rapid growth, projecting a market size of $6.72 billion in 2028, driven by a robust CAGR of 11.3%. Factors contributing to this growth include the advent of personalized and patient-centric airway pressure devices, the surge in telemedicine and remote monitoring, the development of customized devices for specific respiratory conditions, the expansion of telehealth and virtual sleep clinics, and the increased utilization in sports and performance sleep. Key trends in the forecast period encompass the integration of artificial intelligence (AI) and machine learning in sleep disorder management, regulatory compliance in airway pressure device safety, portable and travel-friendly PAP solutions, pediatric and infant-specific PAP devices, and wearable PAP technology for continuous monitoring.

Elevated Prevalence Of Obstructive Sleep Apnea Fueling Positive Airway Pressure (PAP) Devices Market Growth
Addressing Obstructive Sleep Apnea:
The upsurge in obstructive sleep apnea is a significant catalyst propelling the positive airway pressure devices market forward. Obstructive Sleep Apnea (OSA), a prevalent and potentially serious sleep disorder, has witnessed a notable increase. Positive Airway Pressure (PAP) devices emerge as a common and effective treatment for OSA, delivering a continuous or variable stream of pressurized air to keep the airway open during sleep. This effectively prevents or reduces the repetitive airway obstructions characteristic of OSA.

Market Players at the Helm:
Major companies driving the positive airway pressure devices market include ResMed Corporation, Royal Philips N.V., Fisher & Paykel Healthcare Corporation Limited, and Drive DeVilbiss Healthcare Inc. These entities play pivotal roles in developing innovative solutions to meet the evolving demands of the market.

Innovative Product Launches Transform The Positive Airway Pressure (PAP) Devices Market
AirSense 11 PAP Series:
Innovation takes center stage in the positive airway pressure devices market, exemplified by major companies launching groundbreaking products. ResMed Inc. introduced the AirSense 11 PAP Series in August 2021. This series, designed to treat sleep apnea with PAP devices, boasts features such as an integrated humidifier, AutoRamp technology, and an intuitive touchscreen. The AirSense 11 series includes three distinct models—AutoSet, CPAP, and Elite—providing flexibility for users to switch between APAP and CPAP therapy based on individual needs.

Strategic Acquisitions for Market Expansion:
In a strategic move in March 2022, Owens & Minor, Inc. acquired Apria, Inc. for $1.6 billion. This acquisition not only enhanced Owens & Minor’s comprehensive healthcare solutions but also broadened the spectrum of products and distribution channels for individuals with chronic and non-chronic ailments. Apria, Inc., a leading provider of home healthcare equipment, including continuous positive airway pressure, played a crucial role in fortifying Owens & Minor’s market presence.

Navigating Positive Airway Pressure Devices Market Segmentation
Detailed Segmentation:
The positive airway pressure devices market is segmented based on product type, application, and end-user. Product types include Continuous Positive Airway Pressure (CPAP), Auto-titrating Positive Airway Pressure (APAP), and BiLevel Positive Airway Pressure (BiPAP). Applications cover Sleep Apnea, COPD, and other medical applications, while end-users span hospitals & sleep labs, home care settings, and other healthcare providers.

Regional Dynamics:
North America emerged as the largest region in the positive airway pressure devices market in 2023, and Asia-Pacific is predicted to witness the fastest growth during the forecast period, underscoring the global nature of this burgeoning market.

Conclusion: Paving the Way for Healthier Sleep
In conclusion, the positive airway pressure devices market not only reflects impressive past growth but also promises an optimistic trajectory ahead. With an increasing focus on personalized, technologically advanced solutions and strategic partnerships, the market is set to revolutionize the landscape of respiratory therapy. As we navigate towards a future where sleep disorders are managed with precision and innovation, the positive airway pressure devices market stands as a beacon of transformative healthcare solutions.

View More On The Positive Airway Pressure Devices Market Report 2024 – https://www.thebusinessresearchcompany.com/report/positive-airway-pressure-devices-global-market-report

Request A Sample Of The Global Positive Airway Pressure Devices Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=4120&type=smp

January 19, 2024
Future Growth Forecast For The Inflammatory Bowel Disease Treatment Global Market 2024-2033

The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.

The inflammatory bowel disease treatment market has witnessed substantial growth, surging from $23.49 billion in 2023 to a projected $25.56 billion in 2024, reflecting a commendable compound annual growth rate (CAGR) of 8.8%. This growth is attributed to factors such as the increased prevalence of inflammatory bowel disease (IBD), a surge in demand for biologics and immunomodulators, advancements in treatment options, a growing geriatric population, and heightened awareness about the disease.

Anticipating Strong Growth: A Forward Outlook

Looking ahead, the inflammatory bowel disease treatment market is poised for continued robust growth, projecting a market size of $36.63 billion in 2028, driven by a CAGR of 9.4%. Contributing factors in the forecast period include escalating investment in research and development activities, a growing demand for biosimilars, an increase in the incidence of inflammatory bowel disease in emerging markets, a rising demand for personalized medicine, and the integration of precision medicine in IBD treatment. Key trends in the forecast period encompass a surge in product launches and approvals, personalized dosing and treatment plans in IBD management, the adoption of telemedicine for remote monitoring of IBD patients, exploration of microbiome-based therapies for IBD, and the adoption of value-based care models in IBD treatment.

The Surge In Inflammatory Bowel Diseases Spurs Growth In Treatment Market

Rising Prevalence of Crohn’s Disease and Ulcerative Colitis:

The substantial rise in the prevalence of Crohn’s disease and ulcerative colitis is a significant driver for the inflammatory bowel disease treatment market. These types of inflammatory bowel diseases cause inflammation and ulcers in the digestive tracts, necessitating effective treatment options. The United States National Library of Medicine reported in March 2022 that around 1.6 million Americans currently suffer from Crohn’s disease or ulcerative colitis, with approximately 70,000 new cases diagnosed annually. This surge in cases underscores the pressing need for effective treatments, contributing to the market’s growth. Key players such as AbbVie Inc., Biogen Inc., and Johnson & Johnson play pivotal roles in meeting this demand.

View More On The Inflammatory Bowel Disease Treatment Market Report 2024 – https://www.thebusinessresearchcompany.com/report/inflammatory-bowel-disease-treatment-global-market-report

Embracing Technological Advancements In Inflammatory Bowel Disease Treatment

Integration of Artificial Intelligence (AI):

Technological advancement stands out as a key trend in the inflammatory bowel disease treatment market, with a focus on leveraging artificial intelligence (AI) for drug discovery processes and offering advanced treatment options. Notably, CytoReason, an Israeli technology start-up, partnered with Ferring Pharmaceuticals in May 2021 to develop new IBD treatments using AI technology. This collaboration combines Ferring’s medical expertise with CytoReason’s AI technology to create cell-centered illness models, providing critical insights into the body’s functioning at the cellular level.

Strategic Acquisitions for Therapeutic Advancements:

In March 2022, Pfizer Inc. acquired Arena Pharmaceuticals Inc. for $6.7 billion, enhancing its capabilities in the Inflammation and Immunology therapeutic area. This strategic acquisition positions Pfizer to develop therapies for immuno-inflammatory diseases and continue the clinical development of current drug candidates. Arena Pharmaceuticals, Inc., with its focus on novel treatments for immuno-inflammatory illnesses, contributes valuable assets to Pfizer’s research and development efforts.

Navigating Inflammatory Bowel Disease Treatment Market Segmentation

Segment Overview:

The inflammatory bowel disease treatment market is segmented based on drug class, type, route of administration, and distribution channel. Drug classes include Aminosalicylates, Corticosteroids, TNF inhibitors, IL inhibitors, Anti-integrin, JAK inhibitors, and Other Drug Classes. Types encompass Crohn’s Disease and Ulcerative Colitis. Routes of administration include Oral and Injectable options, while distribution channels cover Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy.

Regional Dynamics:

North America dominated the inflammatory bowel disease treatment market in 2023, reflecting the region’s focus on healthcare innovation. Asia-Pacific is anticipated to be the fastest-growing region in the forecast period, highlighting the global nature of the market and the rising incidence of inflammatory bowel disease in emerging markets.

Conclusion: Charting a Course for Future Wellness

In conclusion, the inflammatory bowel disease treatment market is not only witnessing significant growth but is also evolving with technological advancements and strategic acquisitions. The forecasted trends, including the exploration of microbiome-based therapies and the adoption of value-based care models, promise a dynamic future for IBD treatment. The collaborative efforts of major pharmaceutical companies, technology innovators, and healthcare providers will continue to shape the landscape of inflammatory bowel disease treatment, ensuring better outcomes for patients globally.

Request A Sample Of The Global Inflammatory Bowel Disease Treatment Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=6704&type=smp

January 19, 2024
What’s The Growth Forecast For Peripheral IV Catheters Market Through 2024-2033?
The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.

The peripheral IV catheters market has witnessed robust growth, driven by factors such as increased healthcare facilities, an aging population, and the demand for vascular access devices.

Current Market Size
- Surging from $5.19 billion in 2023 to $5.58 billion in 2024.
- A notable Compound Annual Growth Rate (CAGR) of 7.4% signifies the market’s strength.
Historical Contributors
- Growing healthcare facilities.
- Aging population and prevalence of chronic diseases.
- Surgical and medical procedures.
- Increased hospital admissions.
- Rising demand for vascular access devices.
Anticipating Strong Growth Ahead
Projected Expansion
- The market is forecasted to reach $7.67 billion in 2028.
- A compound annual growth rate (CAGR) of 8.3% indicates continued robust growth.
Future Growth Drivers
- Minimally invasive procedures and catheters.
- Short peripheral catheters for outpatient care.
- Prevention of catheter-related bloodstream infections.
- Expansion of home healthcare.
- Integration of antimicrobial coatings.
Emerging Trends in the Forecast Period
Ultrasound-Guided Catheter Insertion
- A significant trend in the forecast period.
- Utilizing ultrasound for precise peripheral IV catheter insertion.
Focus on Reduced Complications
- Emphasis on minimizing complications and catheter failure.
- Advancements in catheter design and technology contribute to improved patient outcomes.
Wireless Communication for Monitoring
- Integration of wireless communication for catheter monitoring.
- Real-time monitoring enhances patient care and streamlines healthcare processes.
Patient-Centered Catheter Care
- A shift towards patient-centered catheter care.
- Tailoring catheter solutions to individual patient needs for enhanced comfort and effectiveness.
Transition to Disposable Catheters
- A notable trend in the forecast period.
- Increased preference for disposable catheters for their convenience and reduced infection risk.
View More On The Peripheral IV Catheters Market Report 2024 – https://www.thebusinessresearchcompany.com/report/peripheral-iv-catheters-global-market-report

Chronic Diseases Fueling Market Growth
Rising Chronic Disease Prevalence
- A significant driver of market expansion.
- Peripheral IV catheters play a crucial role in managing chronic conditions like cancer and cardiovascular diseases.
Statistics on Chronic Illness
- According to the Australian Bureau of Statistics, almost half of the population (46.6%) had at least one chronic illness in March 2022.
- Common chronic conditions included mental and behavioral problems (20.1%), back pain (15.7%), and arthritis (12.5%).
Market Leaders
- Key companies driving the market include Becton, Dickinson and Company, B. Braun Melsungen AG, and Smiths Medical Inc.
Innovations Shaping the Market
Peripheral Intravascular Lithotripsy (IVL) Catheters
- Innovative advancements in peripheral IV catheters.
- Peripheral intravascular lithotripsy catheters, like Shockwave M5+, break down calcium deposits in blood vessels, enhancing blood flow and vessel function.
BD’s Acquisition of Velano Vascular
- BD’s strategic acquisition of Velano Vascular in July 2021.
- Velano Vascular’s needle-free technology allows high-quality blood draws from existing peripheral intravenous catheters, enhancing patient care and safety.
Market Segmentation
1. Product Types:
  - Short Peripheral Intravenous Catheters.
  - Integrated/Closed Peripheral Intravenous Catheters (PIVC).
2. Technology:
  - Conventional Peripheral Intravenous Catheters (PIVC).
  - Safety Peripheral Intravenous Catheters (PIVC).
3. End Users:
  - Hospitals, Clinics, Ambulatory Surgical Centers, Home Healthcare.
Regional Dynamics
North America’s Leading Role
- North America dominated the peripheral IV catheters market in 2023.
- Expected to maintain its position as the fastest-growing region in the forecast period.
In conclusion, the peripheral IV catheters market continues to evolve, driven by technological innovations, a focus on patient-centered care, and an increasing prevalence of chronic diseases. As the healthcare landscape transforms, peripheral IV catheters play a pivotal role in enhancing patient outcomes and streamlining medical procedures.

Request A Sample Of The Global Peripheral IV Catheters Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=6658&type=smp
January 19, 2024